Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy

被引：8
作者：
Hu, Lianghai [1 ,2 ]
Fawcett, John Paul [3 ]
Gu, Jingkai [1 ,2 ]
机构：
[1] Jilin Univ, Norman Bethune Hosp 1, Inst Translat Med, Clin Pharmacol Ctr, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Coll Life Sci, Res Ctr Drug Metab, Changchun 130023, Jilin, Peoples R China
[3] Univ Otago, Sch Pharm, Dunedin, New Zealand
来源：
ACTA PHARMACEUTICA SINICA B | 2012年 / 2卷 / 02期
关键词：
Drug target; Reactive metabolite; Proteomics; Mass spectrometry;
D O I：
10.1016/j.apsb.2012.02.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Identifying protein targets of bioactive compounds is an effective approach to discover unknown protein functions, identify molecular mechanisms of drug action, and obtain information for optimization of lead compounds. At the same time, metabolic activation of a drug can lead to cytotoxicities. Therefore, it is very important to systemically characterize the drug and its reactive intermediate. Mass spectrometry-based proteomic approach has emerged as the most efficient to study protein functions and modifications. This review will discuss method development for the drug target discovery and the application in different fields including the drug toxicity mechanism caused by reactive metabolites. (C) 2012 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码：126 / 136
页数：11
相关论文
共 85 条
  • [1] Affinity selection-mass spectrometry screening techniques for small molecule drug discovery
    Annis, D. Allen
    Nickbarg, Elliot
    Yang, Xianshu
    Ziebell, Michael R.
    Whitehurst, Charles E.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2007, 11 (05) : 518 - 526
  • [2] Selectivity in Enrichment of cAMP-dependent Protein Kinase Regulatory Subunits Type I and Type II and Their Interactors Using Modified cAMP Affinity Resins
    Aye, Thin Thin
    Mohammed, Shabaz
    van den Toorn, Henk W. P.
    van Veen, Toon A. B.
    van der Heyden, Marcel A. G.
    Scholten, Arjen
    Heck, Albert J. R.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (05) : 1016 - 1028
  • [3] Roscovitine targets, protein kinases and pyridoxal kinase
    Bach, S
    Knockaert, M
    Reinhardt, J
    Lozach, O
    Schmitt, S
    Baratte, B
    Koken, M
    Coburn, SP
    Tang, L
    Jiang, T
    Liang, DC
    Galons, H
    Dierick, JF
    Pinna, LA
    Meggio, F
    Totzke, F
    Schächtele, C
    Lerman, AS
    Carnero, A
    Wan, YQ
    Gray, N
    Meijer, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) : 31208 - 31219
  • [4] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
    Bantscheff, Marcus
    Eberhard, Dirk
    Abraham, Yann
    Bastuck, Sonja
    Boesche, Markus
    Hobson, Scott
    Mathieson, Toby
    Perrin, Jessica
    Raida, Manfred
    Rau, Christina
    Reader, Valerie
    Sweetman, Gavain
    Bauer, Andreas
    Bouwmeester, Tewis
    Hopf, Carsten
    Kruse, Ulrich
    Neubauer, Gitte
    Ramsden, Nigel
    Rick, Jens
    Kuster, Bernhard
    Drewes, Gerard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (09) : 1035 - 1044
  • [5] Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
    Bantscheff, Marcus
    Hopf, Carsten
    Savitski, Mikhail M.
    Dittmann, Antje
    Grandi, Paola
    Michon, Anne-Marie
    Schlegl, Judith
    Abraham, Yann
    Becher, Isabelle
    Bergamini, Giovanna
    Boesche, Markus
    Delling, Manja
    Duempelfeld, Birgit
    Eberhard, Dirk
    Huthmacher, Carola
    Mathieson, Toby
    Poeckel, Daniel
    Reader, Valerie
    Strunk, Katja
    Sweetman, Gavain
    Kruse, Ulrich
    Neubauer, Gitte
    Ramsden, Nigel G.
    Drewes, Gerard
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (03) : 255 - U124
  • [6] Revealing promiscuous drug-target interactions by chemical proteomics
    Bantscheff, Marcus
    Scholten, Arjen
    Heck, Albert J. R.
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (21-22) : 1021 - 1029
  • [7] Detection of covalent adducts to cytochrome P450 3A4 using liquid chromatography mass spectrometry
    Bateman, KP
    Baker, J
    Wilke, M
    Lee, J
    LeRiche, T
    Seto, C
    Day, S
    Chauret, N
    Ouellet, M
    Nicoll-Griffith, DA
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (10) : 1356 - 1361
  • [8] Dendrimers in drug research
    Boas, U
    Heegaard, PMH
    [J]. CHEMICAL SOCIETY REVIEWS, 2004, 33 (01) : 43 - 63
  • [9] Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors
    Brehmer, D
    Godl, K
    Zech, B
    Wissing, J
    Daub, H
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (05) : 490 - 500
  • [10] A review on the interrogation of peptide-metal interactions using electrospray ionization-mass spectrometry
    Carlton, Doug D., Jr.
    Schug, Kevin A.
    [J]. ANALYTICA CHIMICA ACTA, 2011, 686 (1-2) : 19 - 39
123456789